The purpose of this paper was to determine the effects of patient fasting, blood collection method/location, using plasma versus whole blood and storage duration on measurement of glucose.
Estimation of in vivo capillary or venous blood glucose concentration from analysis on stored venous blood or its plasma and use in quality control of near-patient glucose tests.
Felding P, Jensen I, Linnet K, Manford G
Purpose
Conclusion
Using heparin-fluoride venous blood, plasma glucose was 11.8-12.7% higher than whole blood glucose measurements. In non-fasting patients, capillary whole blood glucose was 12% higher than venous whole blood glucose, but in fasting patients, this difference was only 1.6%. Glucose levels in heparin-fluoride venous blood decreased by 6% and 7% in the first 2 h (non-fasting patient) and 4 h (fasting patient) of storage at 4-20 degrees C, respectively, and levels decreased by 9% and 10% after 24 h at 4 or 20 degrees C, respectively. The authors were able to use regression analysis to accurately correct for delayed analysis of glucose in whole blood or plasma.
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient fasting, blood collection method/location, using plasma versus whole blood and storage duration on measurement of glucose. Capillary blood was collected into microcentrifuge tubes containing haemolysing and glucose stabilizing solutions or sodium-fluoride capillary tubes, and blood or plasma was stored at 4-20 degrees C for less than 4 h before freezing. Heparin-fluoride venous blood was stored at 4-20 degrees C for 2 h (non-fasting only) or 4 h (fasting only) before being stored at 20 degrees C. After storage, blood was diluted with haemolysing and glucose stabilizing solutions or centrifuged to obtain plasma before freezing.
Summary of Findings
Using heparin-fluoride venous blood, plasma glucose was 11.8-12.7% higher than whole blood glucose measurements. In non-fasting patients, capillary whole blood glucose was 12% higher than venous whole blood glucose, but in fasting patients, this difference was only 1.6%. Glucose levels in heparin-fluoride venous blood decreased by 6% and 7% in the first 2 h (non-fasting patient) and 4 h (fasting patient) of storage at 4-20 degrees C, respectively, and levels decreased by 9% and 10% after 24 h at 4 or 20 degrees C, respectively. The authors were able to use regression analysis to accurately correct for delayed analysis of glucose in whole blood or plasma. Capillary blood and plasma glucose were strongly correlated with venous plasma glucose (r=0.986, both).
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
CarbohydrateClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Patient diet FastingNon-fastingBiospecimen Acquisition Anatomical location of blood draw CapillaryVeinBiospecimen Acquisition Method of fluid acquisition Finger/heel prick samplingVenipunctureBiospecimen Aliquots and Components Blood and blood products PlasmaWhole bloodBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Storage duration 0 h2 h24 h4 h<4 hStorage Storage temperature 20 degrees C4 degrees C4-20 degrees C